Package 43602-003-05
Brand: hydromorphone hydrochloride
Generic: hydromorphone hydrochloridePackage Facts
Identity
Package NDC
43602-003-05
Digits Only
4360200305
Product NDC
43602-003
Description
500 TABLET in 1 BOTTLE (43602-003-05)
Marketing
Marketing Status
Brand
hydromorphone hydrochloride
Generic
hydromorphone hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b492adee-8ae4-476e-8047-c13fb2136b58", "openfda": {"upc": ["0343602002059", "0343602004053", "0343602003056", "0343602002301"], "unii": ["L960UP2KRW"], "rxcui": ["897696", "897702", "897710"], "spl_set_id": ["4de15afe-d676-4faa-a34d-9b9cb20dbf54"], "manufacturer_name": ["Ascent Pharmaceuticals Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (43602-003-05)", "package_ndc": "43602-003-05", "marketing_start_date": "20180124"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (43602-003-30)", "package_ndc": "43602-003-30", "marketing_start_date": "20180124"}], "brand_name": "HYDROMORPHONE HYDROCHLORIDE", "product_id": "43602-003_b492adee-8ae4-476e-8047-c13fb2136b58", "dosage_form": "TABLET", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "43602-003", "dea_schedule": "CII", "generic_name": "hydromorphone hydrochloride", "labeler_name": "Ascent Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HYDROMORPHONE HYDROCHLORIDE", "active_ingredients": [{"name": "HYDROMORPHONE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA210506", "marketing_category": "ANDA", "marketing_start_date": "20180124", "listing_expiration_date": "20261231"}